Robert Ang, M.B.B.S
2022
In 2022, Robert Ang, M.B.B.S earned a total compensation of $4.5M as President and Chief Executive Officer at Vor Biopharma, a 172% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $285,000 |
|---|---|
| Option Awards | $2,788,445 |
| Salary | $570,000 |
| Stock Awards | $857,325 |
| Other | $20,508 |
| Total | $4,521,278 |
MBBS received $2.8M in option awards, accounting for 62% of the total pay in 2022.
MBBS also received $285K in non-equity incentive plan, $570K in salary, $857.3K in stock awards and $20.5K in other compensation.
Rankings
In 2022, Robert Ang, M.B.B.S' compensation ranked 725th out of 5,736 executives tracked by ExecPay. In other words, MBBS earned more than 87.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 725 out of 5,736 | 87th |
Division Manufacturing | 322 out of 3,125 | 90th |
Major group Chemicals And Allied Products | 102 out of 1,416 | 93rd |
Industry group Drugs | 89 out of 1,317 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 19 out of 291 | 94th |
Source: SEC filing on April 14, 2023.
MBBS' colleagues
We found two more compensation records of executives who worked with Robert Ang, M.B.B.S at Vor Biopharma in 2022.